<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01343095</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00013140</org_study_id>
    <nct_id>NCT01343095</nct_id>
  </id_info>
  <brief_title>Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones</brief_title>
  <official_title>A Randomized Controlled Trial of Direct Noise Reduction in the ICU Using Overnight Application of In-ear Earplugs or In-ear Earplugs Plus Noise-Canceling Headphones to Reduce the Incidence and Duration of ICU Delirium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to examine the effects of overnight noise reduction in critically ill
      patients who are receiving mechanical ventilation. The investigators will randomly place
      subjects into one of three groups: 1) usual care 2) overnight earplugs 3) overnight earplugs
      and noise-canceling headphones. The investigators will monitor for safety, and will measure
      the amount of delirium experienced by subjects, record the amount of sedating and painkilling
      medicines required, and measure sleep quality during the study, among other information. The
      investigators will also measure noise levels experienced by patients in each group. The
      investigators predict that the use of overnight noise reduction will be safe and will reduce
      the amount of delirium by improving the quality of sleep in critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Delirium is an acute confusional state defined by fluctuating mental status, inattention, and
      either disorganized thinking or an altered level of consciousness. Acute delirium is an
      increasingly recognized problem in intensive care units (ICUs) in the US and worldwide. ICU
      Delirium has been estimated to occur in as many as 50 to 80 percent of ICU patients. Delirium
      in the ICU has been associated with worsened clinical outcomes such as prolonged
      hospitalization and death [1-4]. Although noise has been shown to negatively influence sleep
      in the ICU, and sleep disturbance is a recognized contributor to ICU delirium[1-2, 4], there
      is no well-established link between ICU noise levels and the development of ICU delirium.
      Optimal strategies for the prevention and treatment of ICU delirium are yet to be defined,
      and this study will focus on a novel noise-reduction approach which has potential to impact
      both prevention and treatment [5-8]. Findings will be generalizable to other tertiary care
      medical intensive care units caring for adult patients.

      Objectives Our multidisciplinary team will evaluate the safety and feasibility of direct
      noise reduction in the Wake Forest University Baptist Medical Center (WFUBMC) Medical
      Intensive Care Unit (MICU), and any effect on the incidence of ICU delirium.

      Methods and Measures Design

        -  Forty-five (45) patients receiving mechanical ventilation will be randomized to receive
           either passive direct noise reduction (earplugs), both passive and active direct noise
           reduction (earplugs and noise-canceling headphones), or no direct noise reduction (usual
           practice).

        -  Ambient noise levels and the reduction in noise accomplished by direct noise reduction
           will be measured according to standardized audiometric techniques.

        -  Sleep structure, including amount of recovery sleep, will be measured over one night
           according to standardized polysomnographic (sleep study) techniques

        -  The incidence of delirium will be assessed as well as multiple other endpoints including
           but not limited to amount of psychoactive medication prescribed and amount of physical
           restraints required.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Loss of study staff
  </why_stopped>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Days Free of Delirium or Coma</measure>
    <time_frame>During the Study Period (Study Days 0-7 while patients were in ICU)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Noise Attenuation</measure>
    <time_frame>Overnight (10pm-6am) on study day 2 or 3.</time_frame>
    <description>The reduction in noise experienced by the subject when using the study intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency and Architecture</measure>
    <time_frame>Overnight (10pm-6am) on study day 2 or 3</time_frame>
    <description>Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Sedative Use (Midazolam and Lorazepam)</measure>
    <time_frame>During the Study Period (Study Days 0-7)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Analgesic Use</measure>
    <time_frame>During the Study Period (Study Days 0-7)</time_frame>
    <description>Mean of analgesic daily use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Sedative Use (Propofol and Demedetomidine )</measure>
    <time_frame>During the Study Period (Study Days 0-7)</time_frame>
    <description>Mean of sedative daily use (Propofol and Demedetomidine )</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Delirium</condition>
  <condition>Sleep Fragmentation</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care between 10pm-6am</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Earplugs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of foam earplugs from 10pm-6am nightly for seven nights or until ICU discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Earplugs and Headphones</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foam Earplugs and Noise canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foam Earplugs</intervention_name>
    <description>Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
    <arm_group_label>Earplugs</arm_group_label>
    <arm_group_label>Earplugs and Headphones</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noise Canceling Headphones</intervention_name>
    <description>Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
    <arm_group_label>Earplugs and Headphones</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients who are admitted to our MICU for at least 24 hours with at least 72
             hours' additional expected stay in ICU, and who are mechanically ventilated

        Exclusion Criteria:

          -  severe to profound hearing loss

          -  baseline use of hearing aids

          -  eardrum perforation

          -  severe cerumen impaction

          -  head or oromaxillofacial trauma

          -  external ventricular drain or intracranial pressure monitoring devices

          -  comatose patients who are deemed by their attending physician as unlikely to awaken
             within 72 hours

          -  patient status as comfort-measures only

          -  any other contraindication to the use of earplugs or headphones
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew C Miles, MD</last_name>
    <role>Study Director</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2011</study_first_submitted>
  <study_first_submitted_qc>April 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2011</study_first_posted>
  <results_first_submitted>May 3, 2016</results_first_submitted>
  <results_first_submitted_qc>November 21, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 20, 2017</results_first_posted>
  <last_update_submitted>December 21, 2017</last_update_submitted>
  <last_update_submitted_qc>December 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICU Delirium</keyword>
  <keyword>Delirium</keyword>
  <keyword>Sleep Quality</keyword>
  <keyword>Sleep Efficiency</keyword>
  <keyword>ICU Noise</keyword>
  <keyword>Noise Reduction</keyword>
  <keyword>Earplugs</keyword>
  <keyword>Noise Canceling Headphones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Sleep Deprivation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>de-identified data was shared with another investigator as part of a review and meta-analysis</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Usual Care between 10pm-6am</description>
        </group>
        <group group_id="P2">
          <title>Earplugs</title>
          <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
        </group>
        <group group_id="P3">
          <title>Earplugs and Headphones</title>
          <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Usual Care between 10pm-6am</description>
        </group>
        <group group_id="B2">
          <title>Earplugs</title>
          <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
        </group>
        <group group_id="B3">
          <title>Earplugs and Headphones</title>
          <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72" lower_limit="71" upper_limit="73"/>
                    <measurement group_id="B2" value="66" lower_limit="53" upper_limit="71"/>
                    <measurement group_id="B3" value="56" lower_limit="40" upper_limit="77"/>
                    <measurement group_id="B4" value="63" lower_limit="40" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean SAPS II</title>
          <description>Severe Acute Physiology Scale II. The SAPS II score is made of 12 physiological variables and 3 disease-related variables. The worst physiological variables were collected within the first 24 hours of ICU admission. The &quot;worst&quot; measurement was defined as the measure that correlated to the highest number of points. The study did not continually calculate SAPS II scores beyond the first 24 hours of ICU admission. The SAPS II score ranges from 0 to 163 points.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.5" lower_limit="27" upper_limit="88"/>
                    <measurement group_id="B2" value="40" lower_limit="22" upper_limit="68"/>
                    <measurement group_id="B3" value="57.6" lower_limit="43" upper_limit="74"/>
                    <measurement group_id="B4" value="51" lower_limit="22" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Days Free of Delirium or Coma</title>
        <time_frame>During the Study Period (Study Days 0-7 while patients were in ICU)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual Care between 10pm-6am</description>
          </group>
          <group group_id="O2">
            <title>Earplugs</title>
            <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
          </group>
          <group group_id="O3">
            <title>Earplugs and Headphones</title>
            <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
          </group>
        </group_list>
        <measure>
          <title>Days Free of Delirium or Coma</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="2.3" lower_limit="0" upper_limit="6"/>
                    <measurement group_id="O3" value="2" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Noise Attenuation</title>
        <description>The reduction in noise experienced by the subject when using the study intervention.</description>
        <time_frame>Overnight (10pm-6am) on study day 2 or 3.</time_frame>
        <population>Devices were unable to measure noise above 85 dB(A) from the in-ear location; no noise data was collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual Care between 10pm-6am</description>
          </group>
          <group group_id="O2">
            <title>Earplugs</title>
            <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
          </group>
          <group group_id="O3">
            <title>Earplugs and Headphones</title>
            <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
          </group>
        </group_list>
        <measure>
          <title>Noise Attenuation</title>
          <description>The reduction in noise experienced by the subject when using the study intervention.</description>
          <population>Devices were unable to measure noise above 85 dB(A) from the in-ear location; no noise data was collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Efficiency and Architecture</title>
        <description>Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.</description>
        <time_frame>Overnight (10pm-6am) on study day 2 or 3</time_frame>
        <population>Sleep measurement equipment was not available for use during the study period</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual Care between 10pm-6am</description>
          </group>
          <group group_id="O2">
            <title>Earplugs</title>
            <description>Application of foam earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
          </group>
          <group group_id="O3">
            <title>Earplugs and Headphones</title>
            <description>Foam Earplugs and Noise canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Efficiency and Architecture</title>
          <description>Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.</description>
          <population>Sleep measurement equipment was not available for use during the study period</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Sedative Use (Midazolam and Lorazepam)</title>
        <time_frame>During the Study Period (Study Days 0-7)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual Care between 10pm-6am</description>
          </group>
          <group group_id="O2">
            <title>Earplugs</title>
            <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
          </group>
          <group group_id="O3">
            <title>Earplugs and Headphones</title>
            <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Sedative Use (Midazolam and Lorazepam)</title>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Midazolam</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="0" upper_limit="25"/>
                    <measurement group_id="O2" value="10.65" lower_limit="0" upper_limit="79.5"/>
                    <measurement group_id="O3" value="9.22" lower_limit="0" upper_limit="63.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lorazepam</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" lower_limit="0" upper_limit="6"/>
                    <measurement group_id="O2" value="0.40" lower_limit="0" upper_limit="6.5"/>
                    <measurement group_id="O3" value="0.39" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Analgesic Use</title>
        <description>Mean of analgesic daily use</description>
        <time_frame>During the Study Period (Study Days 0-7)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual Care between 10pm-6am</description>
          </group>
          <group group_id="O2">
            <title>Earplugs</title>
            <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
          </group>
          <group group_id="O3">
            <title>Earplugs and Headphones</title>
            <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Analgesic Use</title>
          <description>Mean of analgesic daily use</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fentanyl</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" lower_limit="0" upper_limit="0.55"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0" upper_limit="2.425"/>
                    <measurement group_id="O3" value="0.32" lower_limit="0" upper_limit="2.575"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morphine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0.03" lower_limit="0" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dilaudid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0.07" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrocodone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0.18" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Sedative Use (Propofol and Demedetomidine )</title>
        <description>Mean of sedative daily use (Propofol and Demedetomidine )</description>
        <time_frame>During the Study Period (Study Days 0-7)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual Care between 10pm-6am</description>
          </group>
          <group group_id="O2">
            <title>Earplugs</title>
            <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
          </group>
          <group group_id="O3">
            <title>Earplugs and Headphones</title>
            <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Sedative Use (Propofol and Demedetomidine )</title>
          <description>Mean of sedative daily use (Propofol and Demedetomidine )</description>
          <units>mcg/kg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Propofol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Demedetomidine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.36" lower_limit="0" upper_limit="13.6"/>
                    <measurement group_id="O2" value="0.98" lower_limit="0" upper_limit="9.9"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Usual Care between 10pm-6am</description>
        </group>
        <group group_id="E2">
          <title>Earplugs</title>
          <description>Application of earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)</description>
        </group>
        <group group_id="E3">
          <title>Earplugs and Headphones</title>
          <description>Earplugs and Noise-canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Foam Earplugs: Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Noise Canceling Headphones: Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Matthew C. Miles</name_or_title>
      <organization>Wake Forest Baptist Health</organization>
      <phone>336-716-7765</phone>
      <email>mmiles@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

